Publication | Open Access
Distinguishing Score 0 From Score 1+ in HER2 Immunohistochemistry-Negative Breast Cancer
93
Citations
13
References
2013
Year
In a setting with stringent quality assurance, score 0 and score 1+ tumors emerge as distinct and clinically important subgroups within the HER2 IHC-negative population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1